Ovarian Cancer

Chemotherapy helps women with localized disease

Published in Health and Medicine Week, October 18th, 2004

A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (i.e., cancer that has not spread beyond the ovary) .

It remains unclear, though, which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.

The findings come from an analytical review of data from 13 randomized control trials (RCTs), which will be published in the November 1, 2004, issue of Cancer. It was published online on September 27, 2004.

About one quarter of all ovarian cancers are caught while confined to the ovaries, when 5-year survival is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2004-10-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry